
Panacea Plant Sciences, a Washington State biotechnology company, has discovered formulations that act synergistically with dimethyltryptamine (DMT). The company announced the findings during the Cannabis Science Conference, on May 19.
The data shows increases of more than 200% at the 5-HT2A receptor when the company's PPS1 and PPS2 drug candidates are combined with DMT.